Author： Tuvlin Jeffrey A Kane Sunanda V
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.3, 2003-03, pp. : 483-490
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Novel therapies in the treatment of ulcerative colitis
Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. :
Access to resources
Recommend
Comparative Tolerability of Therapies for Ulcerative Colitis
Drug Safety, Vol. 25, Iss. 8, 2002-01 ,pp. :
Biologic therapies in ulcerative colitis: primi inter pares?
Current Drug Targets, Vol. 19, Iss. 7, 2018-04 ,pp. :